{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:16:31Z","timestamp":1791951391810,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jaad.2010.05.030","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T10:24:23Z","timestamp":1304936663000},"page":"855-862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Evaluation of cutaneous angioimmunoblastic T-cell lymphoma"],"prefix":"10.1016","volume":"65","author":[{"given":"Brundha","family":"Balaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarod A.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Sheinbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.05.030_bib1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(74)90553-4","article-title":"Angio-immunoblastic lymphadenopathy with dysproteinemia","volume":"1","author":"Frizzera","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2010.05.030_bib2","first-page":"347","article-title":"Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma","volume":"9","author":"Shimoyama","year":"1979","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jaad.2010.05.030_bib3","series-title":"Tumors of the haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.jaad.2010.05.030_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2010.05.030_bib5","first-page":"899","article-title":"Evaluation and management of angioimmunoblastic T-cell lymphoma: A\u00a0review of current approaches and future strategies","volume":"6","author":"Alizadeh","year":"2008","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.jaad.2010.05.030_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1309\/28YP0DELGKEJGRXG","article-title":"Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma: emphasis on phenotypic aberrancies for early diagnosis","volume":"126","author":"Merchant","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib7","first-page":"707","article-title":"Angio-immunoblastic lymphadenopathy. A\u00a0report of 3 cases","volume":"50","author":"Jacobson","year":"1976","journal-title":"S\u00a0Afr Med J"},{"key":"10.1016\/j.jaad.2010.05.030_bib8","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archderm.1977.01640050096015","article-title":"Immunoblastic lymphadenopathy with purpura and cryoglobulinemia","volume":"113","author":"Wechsler","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1978.01640130056016","article-title":"Angioimmunoblastic lymphadenopathy","volume":"114","author":"Matloff","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(78)90884-X","article-title":"Skin biopsy in angioimmunoblastic lymphadenopathy","volume":"1","author":"Meijer","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2010.05.030_bib11","first-page":"227","article-title":"Cutaneous manifestations of angioimmunoblastic lymphadenopathy","volume":"1","author":"Bernstein","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archderm.1980.01640250043013","article-title":"Cutaneous manifestations of angioimmunoblastic lymphadenopathy","volume":"116","author":"Seehafer","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2133.1981.tb00034.x","article-title":"Skin lesions in angioimmunoblastic lymphadenopathy: histological and immunological studies","volume":"104","author":"Bernengo","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib14","first-page":"235","article-title":"Angioimmunoblastic lymphadenopathy with scleromyxedema-like lesions and serum monoclonal protein","volume":"19","author":"Rahmani","year":"1983","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.jaad.2010.05.030_bib15","first-page":"445","article-title":"Transient acantholytic dermatosis associated with lymphomatous angioimmunoblastic lymphadenopathy","volume":"69","author":"Zelickson","year":"1989","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2010.05.030_bib16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archderm.1994.01690120091013","article-title":"Fever, maculopapular eruption, and lymphadenopathy","volume":"130","author":"Gross","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1365-2133.1995.tb06937.x","article-title":"Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadenopathy with dysproteinemia","volume":"133","author":"B\u00f6ni","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0190-9622(97)80401-X","article-title":"Cutaneous involvement in prelymphomatous angioimmunoblastic lymphadenopathy","volume":"36","author":"Schmuth","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archderm.136.7.881","article-title":"Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis","volume":"136","author":"Martel","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib20","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1600-0560.2001.028008432.x","article-title":"Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein\u2013Barr virus expression","volume":"28","author":"Brown","year":"2001","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1468-3083.2001.00356.x","article-title":"Angioimmunoblastic T-cell lymphoma with cutaneous involvement","volume":"15","author":"Mahendran","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.05.030_bib22","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1046\/j.1365-2133.2001.04150.x","article-title":"Angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma with cutaneous infiltration: report of a case and its gene expression profile","volume":"144","author":"Murakami","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000478-200305000-00015","article-title":"Angioimmunoblastic lymphadenopathy-like T-cell lymphoma: cutaneous clinical onset with prominent granulomatous reaction","volume":"27","author":"Suarez-Vilela","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-4362.2003.01721.x","article-title":"Cutaneous relapse of angioimmunoblastic lymphadenopathy type peripheral T-cell lymphoma mimicking an exanthematous drug eruption","volume":"42","author":"Yoon","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib25","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.5858\/2004-128-e122-ATLWCI","article-title":"Angioimmunoblastic T-cell lymphoma with cutaneous involvement: a case report with subtle histologic changes and clonal T-cell proliferation","volume":"128","author":"Huang","year":"2004","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaad.2010.05.030_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1440-0960.2005.00177.x","article-title":"Toxic epidermal necrolysis secondary to angioimmunoblastic T-cell lymphoma","volume":"46","author":"Jones","year":"2005","journal-title":"Aust J\u00a0Dermatol"},{"issue":"Suppl. 2","key":"10.1016\/j.jaad.2010.05.030_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0560.2006.00489.x","article-title":"Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology","volume":"33","author":"Jayaraman","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/MD.0b013e3181573059","article-title":"Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients","volume":"86","author":"Lachenal","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2010.05.030_bib29","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/PAS.0b013e31802df4ef","article-title":"Characterization of CXCL13+ neoplastic T cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL)","volume":"31","author":"Ortonne","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/archdermatol.2008.607","article-title":"Atypical linear IgA dermatosis revealing angioimmunoblastic T-cell lymphoma","volume":"145","author":"Nassar","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.05.030_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.194.7.927","article-title":"Survival and clonal expansion of mutating \u201cforbidden\u201d (immunoglobulin receptor-deficient) Epstein-Barr virus-infected b cells in angioimmunoblastic T cell lymphoma","volume":"194","author":"Br\u00e4uninger","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2010.05.030_bib32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.179.4.1173","article-title":"Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines","volume":"179","author":"Lindhout","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2010.05.030_bib33","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1182\/blood.V79.7.1789.1789","article-title":"Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"79","author":"Weiss","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2010.05.030_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1365-2141.2007.06620.x","article-title":"Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load","volume":"138","author":"Zhou","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2010.05.030_bib35","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/0145-2126(93)90049-Q","article-title":"Frequent detection of human herpesvirus-6 sequences by polymerase chain reaction in paraffin-embedded lymph nodes from patients with angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma","volume":"17","author":"Luppi","year":"1993","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaad.2010.05.030_bib36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hon.740","article-title":"T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma","volume":"22","author":"Vrsalovic","year":"2004","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jaad.2010.05.030_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s002960000056","article-title":"Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis","volume":"20","author":"Pay","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2010.05.030_bib38","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2169\/internalmedicine.35.894","article-title":"Salazosulfapyridine-induced angioimmunoblastic lymphadenopathy","volume":"35","author":"Nakano","year":"1996","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2010.05.030_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/030089160308900120","article-title":"Angioimmunoblastic lymphadenopathy with dysproteinemia following doxycycline administration","volume":"89","author":"Batinac","year":"2003","journal-title":"Tumori"},{"key":"10.1016\/j.jaad.2010.05.030_bib40","first-page":"44","article-title":"Angioimmunoblastic T-cell lymphoma (AIL-TCL) following macrolide administration","volume":"59","author":"Sasaki","year":"2000","journal-title":"Hawaii Med J"},{"key":"10.1016\/j.jaad.2010.05.030_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1309\/AJCP62WRKERPXDRT","article-title":"Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma","volume":"131","author":"Yu","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.pas.0000209855.28282.ce","article-title":"Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma","volume":"30","author":"Dorfman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib43","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3324\/haematol.10864","article-title":"Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma","volume":"92","author":"Roncador","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2010.05.030_bib44","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/0008-5472.CAN-05-2154","article-title":"Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human","volume":"66","author":"Morito","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2010.05.030_bib45","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/PAS.0b013e318054dbcf","article-title":"c-Maf expression in angioimmunoblastic T-cell lymphoma","volume":"31","author":"Murakami","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1535-6108(04)00019-4","article-title":"Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma","volume":"5","author":"Hurt","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaad.2010.05.030_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00000478-200401000-00005","article-title":"CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma","volume":"28","author":"Attygalle","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaad.2010.05.030_bib48","first-page":"A38","article-title":"Distribution of CD10, FAS (CD95) and FASL (CD95L) in angioimmunoblastic T-cell lymphoma: implications for the pathogenesis","volume":"55","author":"Kim","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaad.2010.05.030_bib49","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2007-05-088666","article-title":"A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin","volume":"110","author":"Mao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2010.05.030_bib50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0609.2007.00815.x","article-title":"Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience","volume":"78","author":"Rodriguez","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaad.2010.05.030_bib51","first-page":"218","article-title":"High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"26","author":"Kyriakou","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2010.05.030_bib52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/oxfordjournals.annonc.a059281","article-title":"Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group","volume":"6","author":"Siegert","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2010.05.030_bib53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/10428199909058412","article-title":"Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature","volume":"32","author":"Pautier","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2010.05.030_bib54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1996.14.2.593","article-title":"Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type","volume":"14","author":"Schlegelberger","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2010.05.030_bib55","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2010.05.030_bib56","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/labinvest.3700145","article-title":"Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression","volume":"84","author":"Zhao","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaad.2010.05.030_bib57","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(83)92129-3","article-title":"Rash implies poor prognosis in angioimmunoblastic lymphadenopathy [letter]","volume":"1","author":"Archimbaud","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2010.05.030_bib58","first-page":"1149","article-title":"Prognostic factors in angioimmunoblastic lymphadenopathy [letter]","volume":"1","author":"Blanchard","year":"1983","journal-title":"Lancet"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210006213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210006213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:20:45Z","timestamp":1759270845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962210006213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0190962210006213"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.05.030","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of cutaneous angioimmunoblastic T-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}